The synergistic interaction determined isobolographically for the combination of amantadine with MTO in the human metastatic melanoma cell line (FM55M2) deserves further intensive investigation to reveal the molecular mechanism(s) of the action responsible for this favorable interaction. The gene discussed is SELENBP1; the disease is metastatic melanoma.